About: http://data.cimple.eu/news-article/feb05e3cda3d11f8d88c4562bc1c1d9380f3d8811eedaead1b7e5fbb

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/feb05e3cda3d11f8d88c4562bc1c1d9380f3d8811eedaead1b7e5fbb Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday. Seventy-two participants have already received their first dose following approval for the phase 1 trial from Chinese regulatory authorities, BioNTech and Fosun Pharma said in a statement. The vaccine candidate, known as BNT162b1, is one of four based on BioNTech's proprietary mRNA technology. Another, BNT162b2, is being evaluated in a global phase 3 trial conducted by BioNTech and US giant Pfizer which started on July 27. The phase 1 trial in China involves 144 participants who will receive two doses 21 days apart. Those aged 18-55 will be the first to take part, followed by older people. Laboratories around the world are racing to find a vaccine to curb COVID-19, which has claimed more than 700,000 lives and upended the livelihoods of millions. More than 200 candidate vaccines are currently being developed with roughly two dozen at the stage of clinical trials with human volunteers. Several Chinese companies are at the forefront of the global vaccine race, while Russia has said it hopes to be the first in the world to produce a vaccine for the public, with a target date of September. But the medicines will likely face heightened scrutiny given that the regulatory systems in both countries are far more opaque than they are in the West. On top of the BioNTech/Pfizer candidate, two other Western coronavirus vaccines are in final phase three trials: one produced by US biotech firm Moderna and the National Institutes for Health; and the other by the University of Oxford and Britain's AstraZeneca. fec/hmn/spm
schema:headline	German-Chinese coronavirus vaccine trial begins in China
schema:mentions	21 Days USA Gymnastics Pharmaceutical industry University of Oxford AstraZeneca Messenger RNA Russia Pfizer Vaccine China Severe acute respiratory syndrome coronavirus 2 Intermediate scrutiny
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-08-05 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	81 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software